Terms: = Prostate cancer AND RB1, OSRC, ENSG00000139687, 5925, RB, P06400 AND Staging
3 results:
1. Characterizing cyclin-dependent kinase 12(CDK12)-altered aggressive prostate cancer: a twelve-case series.
Iwasawa T; Kosaka T; Yasumizu Y; Hongo H; Yanai Y; Baba Y; Matsumoto K; Nakamura K; Nishihara H; Oya M
Int J Clin Oncol; 2022 Dec; 27(12):1867-1873. PubMed ID: 36271301
[TBL] [Abstract] [Full Text] [Related]
2. Down-regulation of POTEG predicts poor prognosis in esophageal squamous cell carcinoma patients.
Wang L; Li M; Zhan Y; Ban X; Zeng T; Zhu Y; Yun J; Guan XY; Li Y
Mol Carcinog; 2018 Jul; 57(7):886-895. PubMed ID: 29566278
[TBL] [Abstract] [Full Text] [Related]
3. Array CGH as a potential predictor of radiocurability in intermediate risk prostate cancer.
Ishkanian AS; Zafarana G; Thoms J; Bristow RG
Acta Oncol; 2010 Oct; 49(7):888-94. PubMed ID: 20590366
[TBL] [Abstract] [Full Text] [Related]
